Toronto Innovation Acceleration Partners – TIAP – specializes in venture building of
early-stage health science technologies emerging from our members.
TIAP was formerly MaRS Innovation
Our Members
TIAP’s portfolio draws from three universities, nine teaching hospitals and two research institutes. Learn more about our members.Learn More›
Work With Us
Through our member-exclusive funding programs and services, TIAP works with founders to bring their health science technologies to market faster.Learn More›
Recent News

FedDev Ontario Supports TIAP Expansion with a $6.5M in Funding
On October 9, 2020, the Honourable Mélanie Joly, Minister of Economic Development and Official Languages and Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) announced a FedDev Ontario contribution …

TIAP & Amgen Co-funds transformative projects to support new venture development
December 8, 2020
TIAP announces co-funding of transformative projects with Amgen to support new venture development
Toronto Innovation Acceleration Partners (TIAP) is excited to announce co-investments made with a key strategic partner, Amgen Inc., into three …
Webinar: Staying on Target – How to Determine if Your Research Program is Ready for Drug Delivery
Staying on Target: How to Determine if Your Research Program is Ready for Drug Discovery
LAB150 Presents: A 3-part Webinar Series on Drug Discovery and Development
November 17, 2020 – 12-1:30 PM ET
Register here: bit.ly/Stay-On-Target
In the first …

Funding for Zucara Therapeutics Expansion Into ZT-01 Development Program to Type 2 Diabetes
November 2, 2020: Zucara Therapeutics Inc., a diabetes life sciences startup funded by TIAP and adMare BioInnovations, announced today that it has received funding from NRC IRAP and MITAS for its expansion into the …